|
|
|
| Trend in burden of leukemia among people under 35 years in China from 1990 to 2019 |
| LI Jiayi, ZHAO Xinyu, LIU Qinxian, NING Zule, DU Jinlin
|
| Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, Guangdong 523808, China |
|
|
|
|
Abstract Objective To analyze the trend of the burden of leukemia among people under 35 years in China from 1990 to 2019. Methods Incidence, mortality and disability-adjusted life years (DALY) of leukemia among people under 35 years in China from 1990 to 2019 were collected by using the Global Burden of Disease (GBD) Study Database 2019. The trends in leukemia incidence, mortality and DALY rates were analyzed using the average annual percent change (AAPC) and age-period-cohort model. Results From 1990 to 2019, the incidence, mortality and DALY rates of leukemia among people under 35 years in China showed a downward trend (AAPC=-2.336%, -3.604% and -3.589%, all P<0.05), with more pronounced downward trends in females (AAPC=-3.209%, -3.787% and -3.818%, all P<0.05) than in males (AAPC=-2.521%, -3.292% and -3.306%, all P<0.05). According to the age-period-cohort model, the risks of leukemia incidence, mortality and DALY rates decreased with increasing age. Among them, the children under 5 years had the highest risks of leukemia incidence, mortality and DALY rates (RR=4.697, 2.718 and 3.059). Over time, the risks of leukemia incidence, mortality and DALY rates also decreased from 1990-1994 (RR=1.217, 1.264 and 1.296) to 2015-2019 (RR=0.901, 0.696 and 0.691). With regard to birth cohorts, the risks of leukemia incidence, mortality and DALY rates first increased and then decreased, peaking in the 1986-1990 birth cohort (RR=1.335, 1.192 and 1.231). Conclusions The incidence, mortality and DALY rates of leukemia among people under 35 years in China from 1990 to 2019 showed a downward trend. Males and children under 5 years were the key populations for leukemia prevention and control.
|
|
Received: 25 June 2024
Revised: 27 September 2024
Published: 13 December 2024
|
|
|
|
|
|
[1] 戴萌娜,袭燕,尹文强,等.中国居民1990—2019年白血病疾病负担趋势分析[J].中国公共卫生,2022,38(5):539-546.
[2] 喻静,姜海虹,刘欢,等.1990—2019年中国白血病疾病负担变化趋势及危险因素分析[J].公共卫生与预防医学,2022,33(5):23-28.
[3] 马昭君,李伟伟,董建梅,等.1990—2019年江苏省白血病疾病负担分析[J].预防医学,2023,35(4):282-285,290.
[4] SIEGEL R L,MILLER K D,FUCHS H E,et al.Cancer statistics,2022[J].CA Cancer J Clin,2022,72(1):7-33.
[5] MASTERS R K,POWERS D A,HUMMER R A,et al.Fitting age-period-cohort models using the intrinsic estimator:assumptions and misapplications[J].Demography,2016,53(4):1253-1259.
[6] 郑伟,张世勇,杨纶砥,等.基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J].预防医学,2023,35(8):665-668,681.
[7] 欧泽金,余丹峰,梁源浩,等.基于全球疾病负担研究数据分析1990至2017年白血病死亡和伤残调整生命年的变化趋势[J].癌症,2021,40(2):69-81.
[8] LI B J,TANG H,CHENG Z L,et al.The current situation and future trend of leukemia mortality by sex and area in China[J/OL].Front Public Health,2020,8[2024-09-27].https://doi.org/10.3389/fpubh.2020.598215.
[9] DU M B,CHEN W W,LIU K,et al.The global burden of leukemia and its attributable factors in 204 countries and territories:findings from the global burden of disease2019 study and projections to 2030[J/OL].J Oncol,2022[2024-09-27].https://doi.org/10.1155/2022/1612702.
[10] HENLEY S J,WARD E M,SCOTT S,et al.Annual report to the nation on the status of cancer,part 1:national cancer statistics[J].Cancer,2020,126(10):2225-2249.
[11] 中华人民共和国国家卫生健康委员会,国家发展改革委员会,人力资源社会保障部,等.关于开展儿童白血病救治管理工作的通知[EB/OL].[2024-09-27].https://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435429.htm.
[12] 杨丽,彭瑞,叶晓雯.1990—2019年中国白血病归因于各类危险因素的疾病负担分析与模型预测[J].现代预防医学,2023,50(2):205-209,256.
[13] OU Z J,YU D F,LIANG Y H,et al.Analysis of the global burden of disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017[J].Cancer Commun,2020,40(11):598-610.
[14] 王一然. 河南省儿童白血病发病风险预测模型的建立[D].郑州:郑州大学,2018.
[15] 中华人民共和国卫生部.关于开展提高农村儿童重大疾病医疗保障水平试点工作的意见[EB/OL].[2024-09-27].http://www.gov.cn/zwgk/2010-06/10/content_1624580.htm.
[16] 中华人民共和国国家卫生健康委员会,民政部,国家医疗保障局,等.关于开展儿童血液病、恶性肿瘤医疗救治及保障管理工作的通知[EB/OL].[2024-09-27].http://www.gov.cn/zhengce/zhengceku/2019-11/18/content_5453137.htm.
[17] 周洁,谭自明,茹凉.1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J].预防医学,2023,35(3):205-209.
[18] 王兰兰,刘广超,李小凡,等.1990—2019年中国白血病发病率与死亡率年龄-时期-队列分析[J].现代肿瘤医学,2024,32(7):1334-1340.
[19] BRIVIO E,BARUCHEL A,BEISHUIZEN A,et al.Targeted inhibitors and antibody immunotherapies:novel therapies for paediatric leukaemia and lymphoma[J].Eur J Cancer,2022,164:1-17.
[20] COHEN A K,SYME S L.Education:a missed opportunity for public health intervention[J].Am J Public Health,2013,103(6):997-1001. |
| [1] |
YE Zhenmiao, FAN Lihui, ZHENG Yuhang, JIANG Xuexia, LI Huijun, ZHANG Mohan, XIE Yimin, LUO Yongyuan, JIN Xi. Death and life loss due to breast cancer in Wenzhou City[J]. Preventive Medicine, 2024, 36(9): 746-749. |
|
|
|
|
